Diazene JK-279 induces apoptosis-like cell death in human cervical carcinoma cells
S Jakopec1, K Dubravcic, S Polanc
1Department of Molecular Biology, Rudjer Boskovic Institute, Bijenicka cesta 54, HR-10000 Zagreb, Croatia.
Abstract:
Diazene N-phenyl-2-(2-pyridinyl)diazenecarboxamide (JK-279) is a newly synthesized compound, cytotoxic for several tumor cell lines and their drug-resistant sublines. In human cervical carcinoma cells (HeLa), this compound reduced intracellular glutathione content and increased sensitivity to cisplatin. The aim of the present study was to elucidate the molecular mechanisms involved in the cytotoxic effect of diazene JK-279 on HeLa cells. Cytotoxicity was determined by the MTT method. Flow cytometry analysis showed that diazene JK-279 induces G(2)/M phase arrest, mediated by the increase in p21 expression, and accompanied by an alteration in the expression of survivin. The highest concentration of JK-279 altered nuclear morphology in intact cells, showing "apoptosis-like" features. No cleavage of procaspase-3, procaspase-9 and PARP, or altered expression of apoptotic proteins Bcl-2 and Bax were detected. At the same time, PS externalization and internucleosomal DNA cleavage were observed. Partial necrosis was detected as well. Our results demonstrate that cytotoxicity of diazene JK-279 is mostly the consequence of caspase-independent cell death, which is in some aspects "apoptosis-like". Taking into account the multiplicity of mechanisms used by cancer cells to prevent apoptosis, the drugs (like diazene JK-279) that would activate alternative cell death pathways could provide a useful tool for new types of cancer therapy.
Insights
Diazene N-phenyl-2-(2-pyridinyl)diazenecarboxamide (JK-279) exhibits cytotoxicity against HeLa cells by inducing G2/M arrest and caspase-independent cell death. This compound offers potential as a novel cancer therapeutic agent.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Diazene N-phenyl-2-(2-pyridinyl)diazenecarboxamide (JK-279) is a novel cytotoxic compound effective against various tumor cell lines.
- JK-279 reduces intracellular glutathione and enhances cisplatin sensitivity in human cervical carcinoma (HeLa) cells.
Purpose of the Study:
- To investigate the molecular mechanisms underlying the cytotoxic effects of JK-279 in HeLa cells.
- To determine if JK-279-induced cell death is mediated by apoptosis or other pathways.
Main Methods:
- Cytotoxicity assessed using the MTT assay.
- Flow cytometry used to analyze cell cycle progression and apoptosis markers (e.g., PS externalization).
- Western blotting or similar techniques to evaluate protein expression (p21, survivin, caspases, Bcl-2, Bax, PARP).
Main Results:
- JK-279 induced G2/M cell cycle arrest, linked to increased p21 expression and altered survivin levels.
- High concentrations of JK-279 caused apoptosis-like nuclear morphology, but without caspase activation (caspase-3, -9) or PARP cleavage.
- Phosphatidylserine (PS) externalization and internucleosomal DNA fragmentation were observed, indicating programmed cell death.
- Partial necrosis was also detected.
Conclusions:
- The cytotoxicity of JK-279 in HeLa cells is primarily mediated by caspase-independent cell death, exhibiting some features of apoptosis.
- JK-279 activates alternative cell death pathways, making it a promising candidate for cancer therapy, especially against apoptosis-resistant cancers.
Related Concept Videos
Inhibition of Cdk Activity
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Apoptosis
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Aryldiazonium Salts to Azo Dyes: Diazo Coupling


